Top Neurovascular Catheters Companies

Neurovascular Catheters Market size was valued at USD 3.48 Billion in 2024 and is poised to grow from USD 3.73 Billion in 2025 to USD 6.51 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026–2033).

The major challenge in the neurovascular catheters market is the high cost of procedures. Neurovascular procedures are complex and require specialized equipment, skilled healthcare professionals, and significant hospital resources. The high cost of procedures can limit their accessibility to patients, particularly in developing countries, where healthcare infrastructure and resources are limited. 'Medtronic (Galway, Ireland)', 'Boston Scientific (Marlborough, Massachusetts, USA) ', 'Stryker Corporation (Kalamazoo, Michigan, USA) ', 'Penumbra (Alameda, California, USA) ', 'Edwards Lifesciences (Irvine, California, USA) ', 'Terumo Corporation (Tokyo, Japan) ', 'Johnson & Johnson (New Brunswick, New Jersey, USA) ', 'Abbott Laboratories (Abbott Park, Illinois, USA) ', 'B. Braun Melsungen (Melsungen, Germany) ', 'MicroPort Scientific (Shanghai, China) ', 'Integer Holdings Corporation (Plano, Texas, USA) ', 'Cook Medical (Bloomington, Indiana, USA) ', 'Cardinal Health (Dublin, Ohio, USA) ', 'Smith & Nephew (London, United Kingdom) ', 'Teleflex Incorporated (Wayne, Pennsylvania, USA) ', 'Merit Medical Systems (South Jordan, Utah, USA) ', 'Nipro Corporation (Osaka, Japan) ', 'Asahi Intecc (Aichi, Japan) ', 'W. L. Gore & Associates (Newark, Delaware, USA) ', 'Convatec (London, United Kingdom)'

The rising prevalence of neurological disorders such as stroke, aneurysms, and arteriovenous malformations (AVMs) is driving demand for neurovascular catheters. These catheters are used to diagnose and treat these conditions, and as the prevalence of these disorders increases, so too does demand for neurovascular catheters.

The increasing incidence of neurological disorders, such as stroke, aneurysms, and arteriovenous malformations, is driving the demand for neurovascular catheters. According to the World Health Organization (WHO), stroke is the second leading cause of death globally, and the demand for effective treatment options for neurological disorders is increasing.

Due to the presence of significant manufacturers in the area, including Penumbra, Inc., Stryker Corporation, Merit Medical Systems, Inc., and Johnson & Johnson, North America had the lion's share of the market in 2022 (33.23%). For instance, J&J's Cerenovus would invest USD 54.19 million in an Irish research facility's development of stroke devices in February 2022. The Rist Selective Radial Access Catheter and the Rist 079 Radial Access Guide Catheter, a groundbreaking radial access catheter system, will also be available in July 2021 thanks to a Health Canada licence obtained by Medtronic Canada ULC, a division of Medtronic.